Nigeria-based biotechnology startup, Syndicate Bio. has partnered with SophiaGenetics, a cloud-native software firm specializing in data-driven medicine, to become the inaugural laboratory in Africa to offer comprehensive genomic profiling and liquid biopsy services on a continent-wide scale.
The partnership marks a significant milestone in Africa’s healthcare landscape, promising unprecedented access to cutting-edge genomic technologies previously unavailable to patients across the continent.
By leveraging Sophia Genetics’ expertise in cloud-based healthcare solutions, Syndicate Bio aims to democratize genetic testing and empower healthcare providers with advanced diagnostic capabilities.
According to the Chief Medical Officer of SOPHiA Genetics’, who highlighted the laboratory’s role in shaping global healthcare through the creation of comprehensive datasets, the significance of this partnership extends beyond immediate clinical impact.
By leveraging data insights, the collaboration aims to drive innovation, accelerate drug discovery, and ultimately improve health outcomes worldwide.